Related Experiment Video
Updated: Mar 2, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Novel Anticoagulant Agents in the Perioperative Setting
Allyson Lemay1, Alan D Kaye2, Richard D Urman1
1Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Novel oral anticoagulants (NOACs) require careful consideration for regional and neuraxial anesthesia. This review covers NOAC pharmacology and perioperative guidelines for safe anesthetic practices.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- The past decade has seen a rise in novel oral anticoagulants (NOACs).
- These agents present unique challenges for anesthetic management.
- Understanding their properties is crucial for patient safety.
Purpose of the Study:
- To review the pharmacology, pharmacokinetics, and pharmacodynamics of commonly used NOACs.
- To outline current guidelines for perioperative NOAC use.
- To specifically address neuraxial anesthesia considerations with NOACs.
Main Methods:
- Literature review of NOACs.
- Analysis of pharmacological and pharmacokinetic data.
- Synthesis of recent clinical guidelines.
Main Results:
- Detailed description of major NOACs' properties.
- Identification of key differences impacting anesthetic choices.
- Summary of evidence-based recommendations for perioperative management.
Conclusions:
- NOACs necessitate tailored anesthetic plans.
- Adherence to updated guidelines ensures safe neuraxial anesthesia.
- Further research may refine perioperative NOAC management.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management

